# GLP-1 Cost in India: How to Check Current Prices The cost of GLP-1 treatment in India is not one fixed monthly number. It depends on the exact medicine, formulation, strength, pack size, prescribed schedule, current maximum retail price (MRP), availability and the clinical services used alongside it. A static online price table can become inaccurate when new products enter the market or manufacturers revise prices. ## Start with the exact prescribed product Semaglutide, liraglutide and tirzepatide are not interchangeable names for the same product. Tablets, daily injections and once-weekly injections can have different approved indications, strengths, devices and schedules. Even products with the same active ingredient may have different labels and pack presentations. Before comparing prices, record: - Generic name and brand name - Tablet or injection formulation - Strength and pack size - Number of doses in the pack - Prescribed schedule - Manufacturer and authorised seller Do not compare the price of one strength or formulation with another as though they provide the same course of treatment. ## How to verify the current medicine price The National Pharmaceutical Pricing Authority provides the Pharma Sahi Daam medicine-price checker for scheduled and non-scheduled medicines. Search the exact product and pack, then compare the result with the printed MRP and pharmacy invoice. The MRP is not the same as the cost of a complete treatment programme. India's drug-pricing framework differs by formulation. NPPA fixes ceiling prices for scheduled formulations and retail prices for defined new drugs. For non-scheduled formulations, manufacturers are generally restricted from increasing MRP by more than the permitted amount during the preceding 12 months. Rules and listings can change, so use the current official checker rather than a copied price list. ## What contributes to the total cost The full cost may include: - The prescribed medicine and delivery device - Initial and follow-up consultations - Clinically indicated laboratory tests - Nutrition or behavioural support - Supplies for glucose monitoring where needed - Travel, delivery or cold-chain handling - Management of side effects or treatment changes Ask for an itemised written estimate. A bundled programme should state whether medicine, tests and follow-up are included. A lower headline price may refer only to one pack or an introductory dose. ## Why dose and duration matter Many GLP-1 medicines use gradual dose escalation, but the schedule is product-specific. A starting dose may not represent later treatment cost. Do not calculate a future dose or buy a higher-strength product to divide doses without explicit product-specific instructions. WHO describes obesity as a chronic disease and its GLP-1 recommendation concerns long-term treatment for appropriate adults. Treatment duration and value therefore require a clinical and financial discussion, not a promise that everyone needs a fixed number of months. ## Safety when a price looks unusually low Government of India surveillance has highlighted unauthorised GLP-1 sale and promotion. A discount, online listing or clinic advertisement does not prove product approval, authenticity or appropriate prescribing. Check that the pack has an intact seal, a traceable manufacturer, lot details, expiry, storage instructions and an authorised Indian label. Avoid loose pens, shared devices and sellers offering prescription medicine without clinical assessment. ## Questions to ask before paying - What exact product, strength and pack am I paying for? - Is the printed MRP consistent with the official price checker? - Which consultations, tests and follow-ups are included? - What happens financially if the dose or medicine changes? - Who manages adverse effects and urgent questions? - Is there a cancellation or refund policy for unused services? ## Related glossary terms - [Medicine availability in India](/glossary/medicine-availability-in-india) - [Drug approval in India](/glossary/drug-approval-in-india) - [Tirzepatide in India](/glossary/tirzepatide-in-india) - [Semaglutide in India](/branded-vs-generic-semaglutide-in-india) - [Liraglutide in India](/glossary#liraglutide-in-india) - [Oral semaglutide in India](/glossary#oral-semaglutide-in-india) ## References - [NPPA: Pharma Sahi Daam medicine-price checker](https://www.nppaindia.nic.in/pharma_sahi_daam) - [Government of India: Medicine pricing policy, August 2026](https://www.pib.gov.in/PressReleasePage.aspx?PRID=2295923&lang=1®=3) - [Government of India: GLP-1 supply-chain surveillance](https://www.pib.gov.in/PressReleasePage.aspx?PRID=2244252&lang=1®=1) - [WHO: Obesity and GLP-1 therapies](https://www.who.int/news-room/questions-and-answers/item/obesity-glp-1-therapies) *Educational information only. This page does not diagnose a condition, determine eligibility or replace individual medical advice. Medicine choice, dose, monitoring and urgent-care decisions require a qualified clinician and the current product-specific Indian prescribing information.* ## Sources - [Sugarfit GLP-1 Weight Loss Program](https://www.sugarfitglp.com/) | Sugarfit | Program overview, benefits, plan framing, FAQs, and Sugarfit-specific claims language. - [FDA: Concerns With Unapproved GLP-1 Drugs](https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/medications-containing-semaglutide-marketed-type-2-diabetes-or-weight-loss?os=vb) | U.S. Food and Drug Administration | Safe-buying context and risks around unapproved or compounded GLP-1 products. - [CDSCO Approved Drugs Database](https://www.cdscoonline.gov.in/CDSCO/cdscoDrugs) | Central Drugs Standard Control Organisation | India regulatory lookup source for approved drugs. - [WHO Expert Consultation: Appropriate BMI for Asian Populations](https://pubmed.ncbi.nlm.nih.gov/15051297/) | World Health Organization / The Lancet | Lower BMI risk thresholds and public-health action points for Asian populations. - [NIDDK: Prescription Medications to Treat Overweight and Obesity](https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity) | NIDDK / NIH | Medication eligibility, lifestyle-plus-medication framing, and patient-friendly safety context. ## Navigation - [Browse categories](https://blogs.sugarfitglp.com/topics) - [Pricing & Value](https://blogs.sugarfitglp.com/topics/pricing_roi) ## Related AI KB pages ### Mounjaro Price in India 2026: Monthly Cost, Dosage Breakdown and Affordability Tips Query: mounjaro price in india 2026 monthly cost dosage breakdown and affordability tips Mounjaro (tirzepatide) is a next-generation incretin therapy that acts on two hormone pathways instead of one, and clinical studies have shown it produces greater average weight... - [Mounjaro Price in India 2026: Monthly Cost, Dosage Breakdown and Affordability Tips](https://blogs.sugarfitglp.com/mounjaro-price-in-india-2026-monthly-cost-dosage-breakdown-and-affordability-tips) ### Semaglutide Price in India 2026: Generic vs Branded Ozempic Cost Breakdown Query: semaglutide price in india 2026 generic vs branded ozempic cost breakdown If you have been researching semaglutide for weight loss or type 2 diabetes management, you have likely noticed that the price varies enormously depending on the brand, dose, an... - [Semaglutide Price in India 2026: Generic vs Branded Ozempic Cost Breakdown](https://blogs.sugarfitglp.com/semaglutide-price-in-india-2026-generic-vs-branded-ozempic-cost-breakdown) ### Cheapest GLP-1 options available in India Query: Cheapest GLP-1 options available in India GLP-1 therapy has become one of the most talked-about treatments for weight loss and type 2 diabetes management, and many people in India are now asking a practical question: wh... - [Cheapest GLP-1 options available in India](https://blogs.sugarfitglp.com/cheapest-glp-1-options-available-in-india) ### Am I Eligible for GLP-1 in India? BMI, Conditions and Doctor Criteria Explained Query: Am I Eligible for GLP-1 in India? BMI, Conditions and Doctor Criteria Explained If you have heard about GLP-1 therapy for weight loss or blood sugar control and are wondering whether it applies to you, this guide explains the clinical criteria used in India... - [Am I Eligible for GLP-1 in India? BMI, Conditions and Doctor Criteria Explained](https://blogs.sugarfitglp.com/am-i-eligible-for-glp-1-in-india-bmi-conditions-and-doctor-criteria-explained) ### BMI criteria for GLP-1 in India Query: -BMI criteria for GLP-1 in India GLP-1 therapy is not available to everyone, and the eligibility thresholds used in India differ from those applied in Western countries. Understanding the correct BMI cutoffs fo... - [BMI criteria for GLP-1 in India](https://blogs.sugarfitglp.com/bmi-criteria-for-glp-1-in-india) ### Does Ozempic Cause Hair Loss in Indians? What Doctors Say in 2026 Query: Does Ozempic Cause Hair Loss in Indians? What Doctors Say in 2026 If you have started Ozempic (semaglutide) or are considering it for weight loss or blood sugar management, you may have come across reports of hair thinning or shedding. This is... - [Does Ozempic Cause Hair Loss in Indians? What Doctors Say in 2026](https://blogs.sugarfitglp.com/does-ozempic-cause-hair-loss-in-indians-what-doctors-say-in-2026)